Arif Anwar

Sengenics International Pte Ltd. develops arrays used in genomics research. It is a genomics and proteomics-based research and diagnostics company with a range of patented technologies and products that are marketed to pharmaceutical companies, scientists and hospitals. The firm flagship technology is the patented Immunome auto-antibody profiling platform which was spun out from research that was commercialized as a joint collaboration between the University of Oxford and the University of Cambridge. The company is headquartered in Singapore.

Sengenics International Pte Ltd. develops arrays used in genomics research. It is a genomics and proteomics-based research and diagnostics company with a range of patented technologies and products that are marketed to pharmaceutical companies, scientists and hospitals. The firm flagship technology is the patented Immunome auto-antibody profiling platform which was spun out from research that was commercialized as a joint collaboration between the University of Oxford and the University of Cambridge. The company is headquartered in Singapore.

Sengenics International Pte Ltd. develops arrays used in genomics research. It is a genomics and proteomics-based research and diagnostics company with a range of patented technologies and products that are marketed to pharmaceutical companies, scientists and hospitals. The firm flagship technology is the patented Immunome auto-antibody profiling platform which was spun out from research that was commercialized as a joint collaboration between the University of Oxford and the University of Cambridge. The company is headquartered in Singapore.

Sengenics International Pte Ltd. develops arrays used in genomics research. It is a genomics and proteomics-based research and diagnostics company with a range of patented technologies and products that are marketed to pharmaceutical companies, scientists and hospitals. The firm flagship technology is the patented Immunome auto-antibody profiling platform which was spun out from research that was commercialized as a joint collaboration between the University of Oxford and the University of Cambridge. The company is headquartered in Singapore.